1EWQ | B:1542-1761; A:542-765 | CRYSTAL STRUCTURE TAQ MUTS COMPLEXED WITH A HETERODUPLEX DNA AT 2.2 A RESOLUTION |
1FW6 | B:1542-1761; A:542-765 | CRYSTAL STRUCTURE OF A TAQ MUTS-DNA-ADP TERNARY COMPLEX |
1NG9 | B:567-800; A:567-800 | E.COLI MUTS R697A: AN ATPASE-ASYMMETRY MUTANT |
1NNE | A:542-765; B:1542-1765 | CRYSTAL STRUCTURE OF THE MUTS-ADPBEF3-DNA COMPLEX |
1PV4 | E:129-417; A:129-417; B:129-417; C:129-417; D:129-417; F:129-417 | X-RAY CRYSTAL STRUCTURE OF THE RHO TRANSCRIPTION TERMINATION FACTOR IN COMPLEX WITH SINGLE STRANDED DNA |
1PVO | E:129-417; A:129-417; B:129-417; C:129-417; D:129-417; F:129-417 | X-RAY CRYSTAL STRUCTURE OF RHO TRANSCRIPTION TERMINATION FACTOR IN COMPLEX WITH SSRNA SUBSTRATE AND ANPPNP |
1RC8 | A:2-149 | T4 POLYNUCLEOTIDE KINASE BOUND TO 5'-GTCAC-3' SSDNA |
1RPZ | A:2-149 | T4 POLYNUCLEOTIDE KINASE BOUND TO 5'-TGCAC-3' SSDNA |
1RRC | A:2-149 | T4 POLYNUCLEOTIDE KINASE BOUND TO 5'-GTC-3' SSDNA |
1TTT | A:1-213; B:1-213; C:1-213 | PHE-TRNA, ELONGATION FACTOR EF-TU:GDPNP TERNARY COMPLEX |
1XPO | E:129-417; A:129-417; B:129-417; C:129-417; D:129-417; F:129-417 | STRUCTURAL MECHANISM OF INHIBITION OF THE RHO TRANSCRIPTION TERMINATION FACTOR BY THE ANTIBIOTIC BICYCLOMYCIN |
1XPR | E:129-417; A:129-417; B:129-417; C:129-417; D:129-417; F:129-417 | STRUCTURAL MECHANISM OF INHIBITION OF THE RHO TRANSCRIPTION TERMINATION FACTOR BY THE ANTIBIOTIC 5A-FORMYLBICYCLOMYCIN (FB) |
1XPU | E:129-417; A:129-417; B:129-417; C:129-417; D:129-417; F:129-417 | STRUCTURAL MECHANISM OF INHIBITION OF THE RHO TRANSCRIPTION TERMINATION FACTOR BY THE ANTIBIOTIC 5A-(3-FORMYLPHENYLSULFANYL)-DIHYDROBICYCLOMYCIN (FPDB) |
2D7D | A:413-589; A:3-89,A:117-148,A:320-338,A:388-410 | STRUCTURAL INSIGHTS INTO THE CRYPTIC DNA DEPENDENT ATP-ASE ACTIVITY OF UVRB |
2F55 | A:190-326; B:190-326; C:190-326; A:327-430,A:452-483; B:327-430,B:452-483; C:327-430,C:452-483 | TWO HEPATITIS C VIRUS NS3 HELICASE DOMAINS COMPLEXED WITH THE SAME STRAND OF DNA |
2FDC | A:414-594; A:1-89,A:120-148,A:323-338,A:388-410; B:414-593 | STRUCTURAL BASIS OF DNA DAMAGE RECOGNITION AND PROCESSING BY UVRB: CRYSTAL STRUCTURE OF A UVRB/DNA COMPLEX |
2GXA | A:377-577; B:377-577; C:377-577; D:377-577; E:377-577; F:377-577; G:377-577; H:377-577; I:377-577; J:377-577; K:377-577; L:377-577 | CRYSTAL STRUCTURE OF PAPILLOMAVIRUS E1 HEXAMERIC HELICASE WITH SSDNA AND MGADP |
2IS1 | A:280-381,A:545-653; B:280-381,B:552-644; A:2-110,A:190-279; B:3-110,B:190-279 | CRYSTAL STRUCTURE OF UVRD-DNA-SO4 COMPLEX |
2IS2 | A:280-381,A:550-646; B:280-381,B:550-646; A:2-110,A:190-279; B:2-110,B:190-279 | CRYSTAL STRUCTURE OF UVRD-DNA BINARY COMPLEX |
2IS4 | A:280-381,A:543-662; B:280-381,B:548-658; A:1-110,A:190-279; B:1-110,B:190-279 | CRYSTAL STRUCTURE OF UVRD-DNA-ADPNP TERNARY COMPLEX |
2IS6 | A:280-381,A:545-656; B:280-381,B:545-662; A:1-110,A:190-279; B:2-110,B:190-279 | CRYSTAL STRUCTURE OF UVRD-DNA-ADPMGF3 TERNARY COMPLEX |
2NMV | A:413-589; A:3-89,A:117-148,A:320-338,A:388-410 | DAMAGE DETECTION BY THE UVRABC PATHWAY: CRYSTAL STRUCTURE OF UVRB BOUND TO FLUORESCEIN-ADDUCTED DNA |
2PJR | A:11-115,A:194-282; F:711-815,F:894-982; A:283-385,A:546-548; F:983-1085,F:1246-1247 | HELICASE PRODUCT COMPLEX |
3PJR | A:283-385,A:550-652; A:4-112,A:193-282 | HELICASE SUBSTRATE COMPLEX |